CN104789531A - 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 - Google Patents
一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 Download PDFInfo
- Publication number
- CN104789531A CN104789531A CN201510140095.1A CN201510140095A CN104789531A CN 104789531 A CN104789531 A CN 104789531A CN 201510140095 A CN201510140095 A CN 201510140095A CN 104789531 A CN104789531 A CN 104789531A
- Authority
- CN
- China
- Prior art keywords
- stem cells
- umbilical cord
- mesenchymal stem
- cord mesenchymal
- nutrient solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 57
- 210000003954 umbilical cord Anatomy 0.000 title claims abstract description 48
- 230000001939 inductive effect Effects 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 39
- 210000005064 dopaminergic neuron Anatomy 0.000 title claims abstract description 13
- 230000006698 induction Effects 0.000 claims abstract description 40
- 230000004069 differentiation Effects 0.000 claims abstract description 33
- -1 glycoside compound Chemical class 0.000 claims abstract description 12
- 229930182470 glycoside Natural products 0.000 claims abstract description 11
- 210000004027 cell Anatomy 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 31
- 235000015097 nutrients Nutrition 0.000 claims description 28
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 18
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 15
- 229930182555 Penicillin Natural products 0.000 claims description 15
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 15
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 claims description 15
- 229940049954 penicillin Drugs 0.000 claims description 15
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 13
- 210000000265 leukocyte Anatomy 0.000 claims description 10
- 235000019154 vitamin C Nutrition 0.000 claims description 10
- 239000011718 vitamin C Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 229960005322 streptomycin Drugs 0.000 claims description 9
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Natural products CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 9
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 8
- 150000002338 glycosides Chemical class 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 238000004115 adherent culture Methods 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 6
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 claims description 6
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 5
- 230000003321 amplification Effects 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 239000003797 essential amino acid Substances 0.000 claims description 5
- 235000020776 essential amino acid Nutrition 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 4
- 239000002953 phosphate buffered saline Substances 0.000 claims description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 210000004748 cultured cell Anatomy 0.000 claims description 2
- 239000000411 inducer Substances 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 description 18
- 239000000463 material Substances 0.000 description 15
- 210000004700 fetal blood Anatomy 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 6
- 210000001178 neural stem cell Anatomy 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000003291 dopaminomimetic effect Effects 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 230000007831 electrophysiology Effects 0.000 description 4
- 238000002001 electrophysiology Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102100037680 Fibroblast growth factor 8 Human genes 0.000 description 3
- 101001027382 Homo sapiens Fibroblast growth factor 8 Proteins 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000000763 evoking effect Effects 0.000 description 3
- 238000012239 gene modification Methods 0.000 description 3
- 230000005017 genetic modification Effects 0.000 description 3
- 235000013617 genetically modified food Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 210000003716 mesoderm Anatomy 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 102100021796 Sonic hedgehog protein Human genes 0.000 description 2
- 101710113849 Sonic hedgehog protein Proteins 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 210000004116 schwann cell Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- CTENFNNZBMHDDG-UHFFFAOYSA-N Dopamine hydrochloride Chemical compound Cl.NCCC1=CC=C(O)C(O)=C1 CTENFNNZBMHDDG-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 230000001964 calcium overload Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- CVKFXBUVLBFHGO-UHFFFAOYSA-N cobalt 5,10,15,20-tetraphenyl-21,23-dihydroporphyrin Chemical compound [Co].c1cc2nc1c(-c1ccccc1)c1ccc([nH]1)c(-c1ccccc1)c1ccc(n1)c(-c1ccccc1)c1ccc([nH]1)c2-c1ccccc1 CVKFXBUVLBFHGO-UHFFFAOYSA-N 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- ZBHDTYQJAQDBIH-UHFFFAOYSA-N fluoroacetyl chloride Chemical compound FCC(Cl)=O ZBHDTYQJAQDBIH-UHFFFAOYSA-N 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 108700007229 noggin Proteins 0.000 description 1
- 102000045246 noggin Human genes 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000001644 umbilical artery Anatomy 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
序号 | 诱导方式 | 分化比例 |
1(对照) | 不加入诱导物 | 22.15% |
2(对照) | 加入红景天苷 | 82.26% |
3(根据本发明) | 加入式I所示化合物 | 90.07% |
4(根据本发明) | 加入式II所示化合物 | 90.32% |
5(根据本发明) | 加入式III所示化合物 | 91.66% |
6(根据本发明) | 加入式IV所示化合物 | 93.79% |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510140095.1A CN104789531B (zh) | 2015-03-27 | 2015-03-27 | 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510140095.1A CN104789531B (zh) | 2015-03-27 | 2015-03-27 | 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104789531A true CN104789531A (zh) | 2015-07-22 |
CN104789531B CN104789531B (zh) | 2017-10-27 |
Family
ID=53554726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510140095.1A Expired - Fee Related CN104789531B (zh) | 2015-03-27 | 2015-03-27 | 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104789531B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105062970A (zh) * | 2015-08-25 | 2015-11-18 | 北京瑞思德生物医学研究院 | 一种将间充质干细胞诱导成神经细胞的诱导剂及诱导分化完全培养基 |
CN107254443A (zh) * | 2017-07-28 | 2017-10-17 | 广州赛莱拉干细胞科技股份有限公司 | 一种促进骨髓间充质干细胞向神经元分化的诱导培养基和诱导方法 |
CN109266610A (zh) * | 2018-09-19 | 2019-01-25 | 宁波金未生物科技有限公司 | 一种促进间充质干细胞分化为神经元的方法 |
CN110885787A (zh) * | 2018-09-10 | 2020-03-17 | 安胜军 | 脐带间充质干细胞向多巴胺能神经元分化的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117625A (zh) * | 2007-07-12 | 2008-02-06 | 中国人民解放军军事医学科学院野战输血研究所 | 诱导间充质干细胞和脂肪干细胞分化为神经元的方法及其专用培养基 |
CN101914493A (zh) * | 2010-07-16 | 2010-12-15 | 山东省齐鲁干细胞工程有限公司 | 脐带间充质干细胞分化为神经细胞的诱导方法 |
US20130108589A1 (en) * | 2010-07-22 | 2013-05-02 | Affiliated Hospital Of Ningxia Medical University | Method of Producing Neurons from Stem Cells, the Neurons and Uses Thereof |
CN104004713A (zh) * | 2014-05-14 | 2014-08-27 | 安沂华 | 脐带间充质干细胞诱导培养为神经细胞的方法 |
-
2015
- 2015-03-27 CN CN201510140095.1A patent/CN104789531B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117625A (zh) * | 2007-07-12 | 2008-02-06 | 中国人民解放军军事医学科学院野战输血研究所 | 诱导间充质干细胞和脂肪干细胞分化为神经元的方法及其专用培养基 |
CN101914493A (zh) * | 2010-07-16 | 2010-12-15 | 山东省齐鲁干细胞工程有限公司 | 脐带间充质干细胞分化为神经细胞的诱导方法 |
US20130108589A1 (en) * | 2010-07-22 | 2013-05-02 | Affiliated Hospital Of Ningxia Medical University | Method of Producing Neurons from Stem Cells, the Neurons and Uses Thereof |
CN104004713A (zh) * | 2014-05-14 | 2014-08-27 | 安沂华 | 脐带间充质干细胞诱导培养为神经细胞的方法 |
Non-Patent Citations (2)
Title |
---|
WEI JIN等: "Epidermal growth factor promotes the differentiation of stem cells derived from human umbilical cord blood into neuron-like cells via taurine induction in vitro", 《IN VITRO CELL.DEV.BIOL.—ANIMAL》 * |
张明等: "红景天苷诱导间充质干细胞向多巴胺神经分化", 《中华神经外科疾病研究杂志》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105062970A (zh) * | 2015-08-25 | 2015-11-18 | 北京瑞思德生物医学研究院 | 一种将间充质干细胞诱导成神经细胞的诱导剂及诱导分化完全培养基 |
CN105062970B (zh) * | 2015-08-25 | 2017-12-29 | 青岛瑞思科生物科技有限公司 | 一种将间充质干细胞诱导成神经细胞的诱导剂及诱导分化完全培养基 |
CN107254443A (zh) * | 2017-07-28 | 2017-10-17 | 广州赛莱拉干细胞科技股份有限公司 | 一种促进骨髓间充质干细胞向神经元分化的诱导培养基和诱导方法 |
CN107254443B (zh) * | 2017-07-28 | 2020-03-13 | 广州赛莱拉干细胞科技股份有限公司 | 一种促进骨髓间充质干细胞向神经元分化的诱导培养基和诱导方法 |
CN110885787A (zh) * | 2018-09-10 | 2020-03-17 | 安胜军 | 脐带间充质干细胞向多巴胺能神经元分化的方法 |
CN109266610A (zh) * | 2018-09-19 | 2019-01-25 | 宁波金未生物科技有限公司 | 一种促进间充质干细胞分化为神经元的方法 |
CN109266610B (zh) * | 2018-09-19 | 2021-06-25 | 宁波金未生物科技有限公司 | 一种促进间充质干细胞分化为神经元的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104789531B (zh) | 2017-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104774808B (zh) | 将脐带间充质干细胞诱导分化成γ-氨基丁酸能神经元的方法 | |
CN101864395B (zh) | 脐带间充质干细胞体外诱导分化为组织工程皮肤种子细胞 | |
KR20100065338A (ko) | 인간 또는 동물 배아에서 중간엽 줄기세포를 추출 및 그 분비물을 추출하는 방법 | |
CN103142447B (zh) | 一种表皮干细胞活性成分及含有该活性成分的美容制剂 | |
SI2086332T1 (en) | From the bone marrow, mesenchymal stem cells are obtained as a source of neural precursors | |
CN104726406A (zh) | 一种诱导牙髓间充质干细胞分化为神经细胞的方法 | |
CN106754668A (zh) | 一种干细胞培养液及注射液 | |
CN104789531B (zh) | 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 | |
CN104004713A (zh) | 脐带间充质干细胞诱导培养为神经细胞的方法 | |
CN107002035A (zh) | 干细胞组合物和生产用于治疗应用的干细胞的方法 | |
CN102559593A (zh) | 一种从人胚胎干细胞分化成神经细胞的方法 | |
CN101294146B (zh) | 诱导神经干细胞分化的系统及诱导方法 | |
Wu et al. | hMSCs possess the potential to differentiate into DP cells in vivo and in vitro | |
KR101896803B1 (ko) | 인간 만능줄기세포로부터 중간엽 줄기세포로의 분화 유도 생산율을 증가시키는 방법 및 이에 의해 생성된 중간엽 줄기세포 | |
KR20160002248A (ko) | 다공성 막을 가진 세포배양 삽입체를 이용한 배아줄기세포로부터 다분화능 신경능 줄기세포의 분리 방법 | |
CN105087475B (zh) | 一种细胞培养液及其应用以及诱导牙髓干细胞向神经样细胞分化的方法 | |
CN115125192B (zh) | 一种骨髓上清液及其在细胞培养中的应用 | |
CN107164325B (zh) | MSCs来源的少突胶质细胞的制备方法及试剂盒 | |
JP2011211956A (ja) | 幹細胞の未分化維持剤及び増殖促進剤 | |
CN104774807B (zh) | 将脐带间充质干细胞诱导分化成少突胶质细胞的方法 | |
CN111718898B (zh) | 提高滑膜间充质干细胞逆境耐受性的方法及其试剂 | |
CN110628712B (zh) | 基于诱导多能干细胞的治疗级间充质干细胞制备方法及应用 | |
CN103361310A (zh) | 培养基、试剂盒及其用途 | |
CN107056895A (zh) | 诱导骨髓间充质干细胞向肝细胞分化的人工多肽及其生物制品 | |
WO2019221477A1 (ko) | 전구세포 배양액 및 다층 그래핀 필름을 포함하는 줄기세포 분화 촉진용 조성물 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180717 Address after: 100041 401, four floor, 11 Shixing street, Shijingshan District, Beijing. Patentee after: BEIJING CHANGQINGTENG BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 100039 No. 9 unit 9, Yongding Road, Haidian District, Beijing 703 Patentee before: An Yihua |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210512 Address after: 100041 room 2598, 2 / F, 11 Shixing East Street, Shijingshan District, Beijing Patentee after: Beijing Warner Zhongkang Technology Development Co.,Ltd. Address before: 100041 401, four floor, 11 Shixing street, Shijingshan District, Beijing. Patentee before: BEIJING CHANGQINGTENG BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211009 Address after: No. 69, Yongding Road, Haidian District, Beijing 100039 Patentee after: Third Medical Center, General Hospital of the Chinese PLA Address before: Room 2598, floor 2, No. 11, Shixing East Street, Shijingshan District, Beijing 100041 Patentee before: Beijing Warner Zhongkang Technology Development Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171027 |